Model Number ONYXNG22515UX |
Device Problems
Premature Activation (1484); Device Dislodged or Dislocated (2923)
|
Patient Problems
Device Embedded In Tissue or Plaque (3165); Insufficient Information (4580)
|
Event Date 03/13/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
An attempt was made to use one onyx frontier coronary drug eluting stent to treat a lesion.It was reported that the stent self deployed.The stent had to be crushed.No further patient injury reported.
|
|
Manufacturer Narrative
|
Additional information: the target lesion was in the left anterior descending (lad) artery.The device was inspected before use with no issues noted.Negative prep was not performed.Force was not applied to the tip of the device during prep.The lesion was pre-dilated.The stent self-deployed after coming through the guide during placement at the lesion, and the stent dislodged from the balloon.The stent was not in the intended location.The stent had to be crushed with medtronic another stent.The patient is alive.Correction: annex e code.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Additional information: annex d code added.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|